Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

Regarding blinding, you state:"normally it is done when there are safety issues and in case of very long trials such as Alz or cancer and they find that it is futile to proceed further.

This is a short trial - tge results may not be futile but may be not as attractive - safety was established so there was not need to unblind the data but maybe reason enough not to share."

1. If the trial is so short as you state, why do you pine about the long duration of result announcements(I can sympathize with you here, I ain't happy, but announcement of results have not been 'incredibly long")?

2. Results must be shared, good or bad, if material to share holders.